Skip to main content

Advertisement

ADVERTISEMENT

poster

Objectives: Aripiprazole once-monthly 400 mg (AOM 400) is a long-acting injectable formulation of aripiprazole licensed in the US, Canada and Australia for maintenance treatment of adults...
10/08/2020
Introduction: Schizophrenia (SCZ) is a severe mental disorder imposing substantial healthcare burden to society. Data quantifying the non-healthcare societal burden of SCZ is limited, esp...
10/08/2020
Major depressive disorder (MDD) is challenging to treat. Antidepressants are prescribed to manage symptoms; the first step toward effective treatment is for patients to fill their new pre...
10/08/2020
Background: Antipsychotics with reduced dosing frequency may improve adherence and clinical outcomes for patients with schizophrenia. This study compared adherence, persistence, healthcar...
10/08/2020
 INTRODUCTION: The insomnia severity index (ISI) is a self-report instrument that evaluates perception of insomnia severity. In Study 303 (SUNRISE-2), lemborexant (LEM) showed greater red...
10/08/2020
Background: The aim of this analysis was to evaluate the long-term efficacy of lurasidone in achieving response and remission in children and adolescents with bipolar depression.
10/08/2020
College students are an at-risk population for prescription stimulant nonmedical use (NMU; use for any reason or in any way other than prescribed, including misuse/abuse). An online surve...
10/08/2020
Objective: 1. to discern demographic predictors that may extend hospitalization length of stay (LOS) for bipolar disorder (BP) managed with electroconvulsive therapy (ECT), and 2. to stud...
10/08/2020
Background: Despite the availability of effective treatments, outcomes for patients with schizophrenia remain poor. Nonadherence is common early in the disease course, a time when the gre...
10/08/2020
Attention-deficit/hyperactivity disorder (ADHD) treatment rates in adults are low, possibly owing to the discontinuation of care during the transition from adolescence to adulthood. To im...
10/08/2020

Advertisement